Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of January 2023, with a specific reporting date of January 4, 2023. The filing serves to incorporate by reference a press release titled "IceCure Medical CEO Issues Letter to Shareholders," which is attached as Exhibit 99.1.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing to distribute a CEO letter and does not contain a financial statement or performance data.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this document, as it does not contain comparative financial data.
Guidance, Outlook, and Risks
The filing references a letter from the Chief Executive Officer to shareholders but does not summarize the content of that letter, including any guidance, outlook, management commentary, risks, or contingencies. The text only confirms the existence and attachment of the letter.
Key Facts for Investor Verification
- Verify the full text of the "CEO Letter to Shareholders" (Exhibit 99.1) for substantive updates on strategy or operations.
- Confirm that this filing is incorporated by reference into the Company's active Registration Statements on Form F-3 and Form S-8.
- Note that no financial performance data is included in this specific Form 6-K.